GRI BIO INC(GRI)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

GRI GRI BIO INC

交易中 12-18 12:24:00 EST

0.4112

-0.0081

-1.93%

最高0.4199	最低0.4057	成交量35.50万
今开0.4194	昨收0.4193	日振幅3.39%
总市值241.46万	流通市值241.44万	总股本587.21万
成交额14.65万	换手率6.05%	流通股本587.16万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"GRI","market":"US","secType":"STK","nameCN":"GRI BIO INC","latestPrice":0.4112,"timestamp":1766078373754,"preClose":0.4193,"halted":0,"volume":355017,"delay":0,"floatShares":5871600,"shares":5872058,"eps":-13.948769,"marketStatus":"交易中","change":-0.0081,"latestTime":"12-18 12:24:00 EST","open":0.4194,"high":0.4199,"low":0.4057,"amount":146526.9474474,"amplitude":0.033866,"askPrice":0.4176,"askSize":100,"bidPrice":0.4024,"bidSize":100,"shortable":0,"etf":0,"ttmEps":-13.948769,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1766091600000},"marketStatusCode":2,"symbolChange":{"newSymbol":"RDOG","executeDate":"2020-01-02"},"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":0.4193,"sharesOutstanding":1100000,"nav":47.93,"aum":52503274.57,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":0.4299,"preClose":0.4193,"latestTime":"09:25 EST","volume":4821,"amount":2063.42579664,"timestamp":1766067914310},"postHourTrading":{"tag":"盘后","latestPrice":0.4106,"preClose":0.4193,"latestTime":"19:43 EST","volume":147344,"amount":60055.1828,"timestamp":1766018591006},"volumeRatio":0.285023},"requestUrl":"/m/hq/s/GRI","defaultTab":"news","newsList":[{"id":"1193690720","title":"GRI Bio Inc：第二阶段2a研究达到了次要终点，并显示胶原蛋白代谢标志物的改善","url":"https://stock-news.laohu8.com/highlight/detail?id=1193690720","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1193690720?lang=zh_cn&edition=full","pubTime":"2025-12-11 05:28","pubTimestamp":1765402089,"startTime":"0","endTime":"0","summary":"GRI Bio Inc：第二阶段2a研究达到了次要终点，并显示胶原蛋白代谢标志物的改善","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRI","BK4007","BK4139"],"gpt_icon":0},{"id":"1172310436","title":"GRI Bio公布特发性肺纤维化（“IPF”）II期2a研究的积极顶线数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1172310436","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1172310436?lang=zh_cn&edition=full","pubTime":"2025-12-11 05:06","pubTimestamp":1765400771,"startTime":"0","endTime":"0","summary":"GRI Bio公布特发性肺纤维化（“IPF”）II期2a研究的积极顶线数据","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4007","GRI"],"gpt_icon":0},{"id":"1197256579","title":"GRI Bio Inc - 试验达到主要终点及某些次要终点；GRI-0621 耐受性良好 - SEC 备案","url":"https://stock-news.laohu8.com/highlight/detail?id=1197256579","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1197256579?lang=zh_cn&edition=full","pubTime":"2025-12-08 21:14","pubTimestamp":1765199651,"startTime":"0","endTime":"0","summary":"GRI Bio Inc - 试验达到主要终点及某些次要终点；GRI-0621 耐受性良好 - SEC 备案","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","GRI","BK4139"],"gpt_icon":0},{"id":"1109567142","title":"GRI Bio Inc - 接收特发性肺纤维化2a期临床试验的初步数据 - SEC备案","url":"https://stock-news.laohu8.com/highlight/detail?id=1109567142","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1109567142?lang=zh_cn&edition=full","pubTime":"2025-12-08 21:13","pubTimestamp":1765199624,"startTime":"0","endTime":"0","summary":"GRI Bio Inc - 接收特发性肺纤维化2a期临床试验的初步数据 - SEC备案","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","GRI","BK4139"],"gpt_icon":0},{"id":"2589812824","title":"我们找到了离“商业向善”最近的55家公司丨2025“可持续品牌典范”榜单公示","url":"https://stock-news.laohu8.com/highlight/detail?id=2589812824","media":"虎嗅APP","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589812824?lang=zh_cn&edition=full","pubTime":"2025-12-06 21:31","pubTimestamp":1765027860,"startTime":"0","endTime":"0","summary":"历经两个月的公开征集与专业评审后，2025“可持续品牌典范”榜单已于近日正式揭晓。需要指出的是，本次评选中也有部分在ESG领域内享有声誉的企业未能上榜。虎嗅ESG承诺将持续倾听各界声音，认真总结经验，在明年的评选机制、流程设计与考察维度上进一步优化，努力呈现一份更公正、更全面、更具参考价值的可持续品牌典范榜。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MTQzMjE1NjQwMQ==&mid=2656136076&idx=3&sn=d6e34518a3d5cf8bbe5baa9a07aad973&chksm=673dfea6eb2e31c39b6e90501da70e33ccad93d9130b0d6cfdbf3bb32bbbae849ecb0abd6bff&scene=0#rd","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"weixin_highlight","symbols":["GRI","BK4007","BK4139"],"gpt_icon":0},{"id":"2582392464","title":"Gri Bio, Inc.盘中异动 下午盘快速拉升6.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582392464","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582392464?lang=zh_cn&edition=full","pubTime":"2025-11-12 02:01","pubTimestamp":1762884063,"startTime":"0","endTime":"0","summary":"北京时间2025年11月12日02时01分，Gri Bio, Inc.股票出现异动，股价急速上涨6.32%。Gri Bio, Inc.股票所在的生物技术行业中，整体涨幅为1.55%。Gri Bio, Inc.公司简介：GRI Bio Inc是一家临床阶段的生物技术公司，专注于发现、开发和商业化针对与免疫反应失调相关的严重疾病的疗法，这些疾病包括炎症、纤维化和自身免疫性疾病。GRI Bio的项目GRI-0621是一种小分子RAR-beta和gamma双重激动剂，能抑制人类NKT I细胞的活性，使免疫系统恢复到稳态。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111202010394fe1f44&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111202010394fe1f44&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GRI","BK4139","BK4007"],"gpt_icon":0},{"id":"2575732577","title":"Gri Bio, Inc.盘中异动 早盘大幅拉升5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2575732577","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575732577?lang=zh_cn&edition=full","pubTime":"2025-10-15 21:37","pubTimestamp":1760535425,"startTime":"0","endTime":"0","summary":"北京时间2025年10月15日21时37分，Gri Bio, Inc.股票出现异动，股价快速拉升5.24%。Gri Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.10%。Gri Bio, Inc.公司简介：GRI Bio Inc是一家临床阶段的生物技术公司，专注于发现、开发和商业化针对与免疫反应失调相关的严重疾病的疗法，这些疾病包括炎症、纤维化和自身免疫性疾病。GRI Bio的项目GRI-0621是一种小分子RAR-beta和gamma双重激动剂，能抑制人类NKT I细胞的活性，使免疫系统恢复到稳态。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251015213705a6bae766&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251015213705a6bae766&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GRI","BK4139","BK4007"],"gpt_icon":0},{"id":"2568251984","title":"GRI前董事吕建中：构建风险共治、价值共创、标准共建、平台共搭、资源共享的ESG生态圈","url":"https://stock-news.laohu8.com/highlight/detail?id=2568251984","media":"睿见Economy","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568251984?lang=zh_cn&edition=full","pubTime":"2025-09-19 17:41","pubTimestamp":1758274860,"startTime":"0","endTime":"0","summary":"　　9月11日，由世界贸易网点联盟、中国产业发展促进会主办，中国产业发展促进会楼宇经济和总部经济分会、集群智库承办、新浪财经、服贸会官网全程直播的2025全球总部经济大会暨中国楼宇经济北京论坛在京举办。全球报告倡议组织前董事吕建中应邀作为“ESG赋能实体产业和不动产价值创造”圆桌对话主持人出席。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/hy/hyjz/2025-09-19/doc-infqzqqh9626991.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["ESG","BK4139","GRI","BK4007","159717"],"gpt_icon":0},{"id":"1145388353","title":"GRI BIO INC公布特发性肺纤维化2a期研究6周中期肺功能数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1145388353","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1145388353?lang=zh_cn&edition=full","pubTime":"2025-09-11 20:47","pubTimestamp":1757594839,"startTime":"0","endTime":"0","summary":"GRI BIO INC近日发布了其针对特发性肺纤维化(IPF)正在进行的2a期临床研究的6周中期肺功能数据报告。该项研究旨在评估公司药物在治疗这一罕见肺部疾病方面的疗效和安全性。此次公布的中期数据为投资者和医学界提供了该药物研发进展的重要信息。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","GRI","BK4139"],"gpt_icon":0},{"id":"2558416661","title":"Gri Bio, Inc.盘中异动 临近午盘大幅跳水5.56%报1.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558416661","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558416661?lang=zh_cn&edition=full","pubTime":"2025-08-11 23:40","pubTimestamp":1754926838,"startTime":"0","endTime":"0","summary":"北京时间2025年08月11日23时40分，Gri Bio, Inc.股票出现异动，股价快速下挫5.56%。Gri Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.24%。Gri Bio, Inc.公司简介：GRI Bio Inc是一家临床阶段的生物技术公司，专注于发现、开发和商业化针对与免疫反应失调相关的严重疾病的疗法，这些疾病包括炎症、纤维化和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811234039a4824416&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811234039a4824416&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","GRI"],"gpt_icon":0},{"id":"2557037893","title":"Gri Bio, Inc.盘中异动 早盘股价大跌5.43%报1.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557037893","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557037893?lang=zh_cn&edition=full","pubTime":"2025-08-06 22:58","pubTimestamp":1754492315,"startTime":"0","endTime":"0","summary":"北京时间2025年08月06日22时58分，Gri Bio, Inc.股票出现波动，股价快速下挫5.43%。截至发稿，该股报1.22美元/股，成交量4.8788万股，换手率1.95%，振幅4.30%。Gri Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.28%。Gri Bio, Inc.公司简介：GRI Bio Inc是一家临床阶段的生物技术公司，专注于发现、开发和商业化针对与免疫反应失调相关的严重疾病的疗法，这些疾病包括炎症、纤维化和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080622583594d39e67&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080622583594d39e67&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GRI","BK4139","BK4007"],"gpt_icon":0},{"id":"2557155928","title":"你以为你吃的是麻六记，其实不过是代工“盲盒”","url":"https://stock-news.laohu8.com/highlight/detail?id=2557155928","media":"虎嗅APP","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557155928?lang=zh_cn&edition=full","pubTime":"2025-08-06 22:31","pubTimestamp":1754490660,"startTime":"0","endTime":"0","summary":"7月28日，麻六记公开发表声明向消费者道歉，称全力推进退货及妥善的补偿方案。据公开资料，四川白家阿宽食品除为麻六记生产酸辣粉外，还为李子柒、三只松鼠、百草味等品牌代工。而信息不透明的结果是，消费者看似购买的是某明星主理品牌，实则吃到的是无法监管的代工“盲盒”。食品安全不是良心工程，而是治理工程麻六记事件无疑警醒了整个行业，贴牌代工如果不纳入品牌ESG治理框架，将成为食品行业最大的“灰犀牛”。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MTQzMjE1NjQwMQ==&mid=2656109958&idx=3&sn=780b2a853abd808e9707d1af78d64535&chksm=67d4ce5438ce466bbf69e9ef5fbb27c00af563bafd7985bd8823b8184b0592823ff0c904db7b&scene=0#rd","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"weixin_highlight","symbols":["BK4007","GRI","BK4139"],"gpt_icon":0},{"id":"2555230860","title":"Gri Bio, Inc.盘中异动 股价大跌5.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555230860","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555230860?lang=zh_cn&edition=full","pubTime":"2025-07-30 23:51","pubTimestamp":1753890684,"startTime":"0","endTime":"0","summary":"北京时间2025年07月30日23时51分，Gri Bio, Inc.股票出现波动，股价快速下跌5.61%。Gri Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.43%。Gri Bio, Inc.公司简介：GRI Bio Inc是一家临床阶段的生物技术公司，专注于发现、开发和商业化针对与免疫反应失调相关的严重疾病的疗法，这些疾病包括炎症、纤维化和自身免疫性疾病。GRI Bio的项目GRI-0621是一种小分子RAR-beta和gamma双重激动剂，能抑制人类NKT I细胞的活性，使免疫系统恢复到稳态。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730235124972818c8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730235124972818c8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","GRI"],"gpt_icon":0},{"id":"2555505820","title":"Gri Bio, Inc.盘中异动 早盘股价大跌6.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555505820","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555505820?lang=zh_cn&edition=full","pubTime":"2025-07-29 23:07","pubTimestamp":1753801652,"startTime":"0","endTime":"0","summary":"北京时间2025年07月29日23时07分，Gri Bio, Inc.股票出现异动，股价快速下挫6.06%。Gri Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.41%。Gri Bio, Inc.公司简介：GRI Bio Inc是一家临床阶段的生物技术公司，专注于发现、开发和商业化针对与免疫反应失调相关的严重疾病的疗法，这些疾病包括炎症、纤维化和自身免疫性疾病。GRI Bio的项目GRI-0621是一种小分子RAR-beta和gamma双重激动剂，能抑制人类NKT I细胞的活性，使免疫系统恢复到稳态。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507292307339725a9f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507292307339725a9f6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GRI","BK4139","BK4007"],"gpt_icon":0},{"id":"2551121615","title":"Gri Bio, Inc.盘中异动 股价大涨5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551121615","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551121615?lang=zh_cn&edition=full","pubTime":"2025-07-16 23:34","pubTimestamp":1752680093,"startTime":"0","endTime":"0","summary":"北京时间2025年07月16日23时34分，Gri Bio, Inc.股票出现异动，股价急速拉升5.56%。Gri Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.96%。Gri Bio, Inc.公司简介：GRI Bio Inc是一家临床阶段的生物技术公司，专注于发现、开发和商业化针对与免疫反应失调相关的严重疾病的疗法，这些疾病包括炎症、纤维化和自身免疫性疾病。GRI Bio的项目GRI-0621是一种小分子RAR-beta和gamma双重激动剂，能抑制人类NKT I细胞的活性，使免疫系统恢复到稳态。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716233453a6add1b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716233453a6add1b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GRI","BK4007","BK4139"],"gpt_icon":0},{"id":"2551637187","title":"Gri Bio, Inc.盘中异动 早盘股价大涨5.72%报1.76美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551637187","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551637187?lang=zh_cn&edition=full","pubTime":"2025-07-14 23:01","pubTimestamp":1752505303,"startTime":"0","endTime":"0","summary":"北京时间2025年07月14日23时01分，Gri Bio, Inc.股票出现波动，股价快速上涨5.72%。Gri Bio, Inc.股票所在的生物技术行业中，整体涨幅为1.19%。Gri Bio, Inc.公司简介：GRI Bio Inc是一家临床阶段的生物技术公司，专注于发现、开发和商业化针对与免疫反应失调相关的严重疾病的疗法，这些疾病包括炎症、纤维化和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071423014497a5d205&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071423014497a5d205&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GRI","BK4007"],"gpt_icon":0},{"id":"2550639709","title":"Gri Bio, Inc.盘中异动 大幅拉升5.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550639709","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550639709?lang=zh_cn&edition=full","pubTime":"2025-07-12 01:42","pubTimestamp":1752255760,"startTime":"0","endTime":"0","summary":"北京时间2025年07月12日01时42分，Gri Bio, Inc.股票出现异动，股价快速上涨5.91%。Gri Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.56%。Gri Bio, Inc.公司简介：GRI Bio Inc是一家临床阶段的生物技术公司，专注于发现、开发和商业化针对与免疫反应失调相关的严重疾病的疗法，这些疾病包括炎症、纤维化和自身免疫性疾病。GRI Bio的项目GRI-0621是一种小分子RAR-beta和gamma双重激动剂，能抑制人类NKT I细胞的活性，使免疫系统恢复到稳态。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071201424097a2966f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071201424097a2966f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GRI","BK4139","BK4007"],"gpt_icon":0},{"id":"2550626401","title":"Gri Bio, Inc.盘中异动 股价大跌5.42%报1.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550626401","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550626401?lang=zh_cn&edition=full","pubTime":"2025-07-10 22:04","pubTimestamp":1752156294,"startTime":"0","endTime":"0","summary":"北京时间2025年07月10日22时04分，Gri Bio, Inc.股票出现异动，股价急速下挫5.42%。截至发稿，该股报1.57美元/股，成交量3.9736万股，换手率1.69%，振幅4.82%。Gri Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.16%。Gri Bio, Inc.公司简介：GRI Bio Inc是一家临床阶段的生物技术公司，专注于发现、开发和商业化针对与免疫反应失调相关的严重疾病的疗法，这些疾病包括炎症、纤维化和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710220454a6a1cbeb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710220454a6a1cbeb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CGTX","BK4139","GRI","BK4007"],"gpt_icon":0},{"id":"2549852841","title":"Gri Bio, Inc.盘中异动 股价大涨5.44%报1.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2549852841","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549852841?lang=zh_cn&edition=full","pubTime":"2025-07-08 21:37","pubTimestamp":1751981832,"startTime":"0","endTime":"0","summary":"北京时间2025年07月08日21时37分，Gri Bio, Inc.股票出现波动，股价急速拉升5.44%。截至发稿，该股报1.55美元/股，成交量2.6306万股，换手率1.12%，振幅3.33%。Gri Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.14%。Gri Bio, Inc.公司简介：GRI Bio Inc是一家临床阶段的生物技术公司，专注于发现、开发和商业化针对与免疫反应失调相关的严重疾病的疗法，这些疾病包括炎症、纤维化和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708213712979e638e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708213712979e638e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GRI","BK4007","BK4139"],"gpt_icon":0},{"id":"2548842758","title":"Gri Bio, Inc.盘中异动 下午盘快速拉升5.42%报1.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548842758","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548842758?lang=zh_cn&edition=full","pubTime":"2025-07-02 03:18","pubTimestamp":1751397490,"startTime":"0","endTime":"0","summary":"北京时间2025年07月02日03时18分，Gri Bio, Inc.股票出现异动，股价大幅上涨5.42%。Gri Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.55%。Gri Bio, Inc.公司简介：GRI Bio Inc是一家临床阶段的生物技术公司，专注于发现、开发和商业化针对与免疫反应失调相关的严重疾病的疗法，这些疾病包括炎症、纤维化和自身免疫性疾病。GRI Bio的项目GRI-0621是一种小分子RAR-beta和gamma双重激动剂，能抑制人类NKT I细胞的活性，使免疫系统恢复到稳态。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507020318119532ea3d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507020318119532ea3d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","GRI","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.vallon-pharma.com","stockEarnings":[{"period":"1week","weight":-0.6535},{"period":"1month","weight":-0.7379},{"period":"3month","weight":-0.7827},{"period":"6month","weight":-0.6823},{"period":"1year","weight":-0.9684},{"period":"ytd","weight":-0.9702}],"compareEarnings":[{"period":"1week","weight":-0.0235},{"period":"1month","weight":0.0086},{"period":"3month","weight":0.0138},{"period":"6month","weight":0.1298},{"period":"1year","weight":0.1111},{"period":"ytd","weight":0.1456}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"GRI Bio, Inc.于2018年1月11日根据特拉华州法律成立。该公司是一家临床阶段的生物制药公司，专注于发现、开发和商业化针对与导致炎症、纤维化和自身免疫性疾病的失调免疫反应相关的严重疾病的创新疗法。该公司的目标是成为开发治疗这些疾病的疗法的行业领导者，并改善患有此类疾病的患者的生活。","exchange":"NASDAQ","name":"GRI BIO INC","nameEN":"GRI BIO INC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"GRI BIO INC(GRI)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供GRI BIO INC(GRI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"GRI BIO INC,GRI,GRI BIO INC股票,GRI BIO INC股票老虎,GRI BIO INC股票老虎国际,GRI BIO INC行情,GRI BIO INC股票行情,GRI BIO INC股价,GRI BIO INC股市,GRI BIO INC股票价格,GRI BIO INC股票交易,GRI BIO INC股票购买,GRI BIO INC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"GRI BIO INC(GRI)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供GRI BIO INC(GRI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}